« Previous
Next »
European Journal of Surgical Oncology
Volume 34, Issue 3
, Pages 333-338
, March 2008
Significance of serum hepatocyte growth factor levels in patients with hepatocellular carcinoma undergoing hepatic resection
References
- . Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med. 1999;340:745–750
- Results of surgical and non-surgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. The Liver Cancer Study Group of Japan. Hepatology. 2000;32:1224–1229
- . Long-term results of hepatic resection for hepatocellular carcinoma originating from the non-cirrhotic liver. Arch Surg. 2004;139:320–325
- . Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma. Ann Surg. 2000;232:10–24
- . Spectrum and significance of microscopic vascular invasion in hepatocellular carcinoma. Surg Oncol Clin N Am. 2003;12:25–34
- Purification and partial characterization of hepatocyte growth factor from plasma of a patient with fulminant hepatic failure. J Clin Invest. 1988;81:414–419
- . Lung may have an endocrine function producing hepatocyte growth factor in response to injury of distal organs. Biochem Biophys Res Commun. 1992;182:802–809
- Expression of hepatocyte growth factor gene in endothelial and Kupffer cells of damaged rat livers, as revealed by in situ hybridization. Biochem Biophys Res Commun. 1990;173:42–47
- . Hepatocyte growth factors: molecular structure and implications for a central role in liver regeneration. J Gastroenterol Hepatol. 1991;6:509–519
- . Expression of HGF, its receptor c-met, c-myc, and albumin in cirrhotic and neoplastic human liver tissue. J Histochem Cytochem. 1997;45:79–87
- . Serum hepatocyte growth factor levels in liver disease: clinical implication. Hepatology. 1995;21:106–112
- . Hepatocyte growth factor/scatter factor induces tyrosine phosphorylation of focal adhesion kinase (p125FAK) and promotes migration and invasion by oral squamous cell carcinoma cells. J Biol Chem. 1994;269:31807–31813
- Human hepatic myofibroblasts increase invasiveness of hepatocellular carcinoma cells: evidence for a role of hepatocyte growth factor. Hepatology. 1997;26:1458–1466
- Direct evidence that hepatocyte growth factor-induced invasion of hepatocellular carcinoma cells is mediated by urokinase. J Hepatol. 1999;30:511–518
- . Increased level of serum hepatocyte growth factor/scatter factor in liver cancer is associated with tumor metastasis. In Vivo. 1999;13:177–180
- Biphasic changes in serum hepatocyte growth factor after transarterial chemoembolization therapy for hepatocellular carcinoma. Cytokine. 1996;8:178–182
- The clinical value of hepatocyte growth factor and its receptor-c-met for liver cancer patients with hepatectomy. Dig Liver Dis. 2006;38:490–497
- . Hepatocyte growth factor (hepatopoietin A) rapidly increases in plasma before DNA synthesis and liver regeneration stimulated by partial hepatectomy and carbon tetrachloride administration. Hepatology. 1991;13:743–749
- . Serum hepatocyte growth factor levels in hepatectomized and non-hepatectomized surgical patients. Gastroenterology. 1992;103:1621–1624
- . Human serum does contain a high molecular weight hepatocyte growth factor: studies pre-and post-hepatic resection. Biochem Biophys Res Commun. 1986;139:361–366
- Portal serum human hepatocyte growth factor levels after partial hepatectomy. Hepatogastroenterology. 1999;46:1078–1082
- Clinical significance of microscopic tumor venous invasion in patients with resectable hepatocellular carcinoma. Surgery. 2000;127:603–608
- . Hepatocyte growth factor for liver disease. Hepatology. 1999;30:333–334
- . Expression of hepatocyte growth factor mRNA, and c-met mRNA (hepatocyte growth factor receptor) in human liver tumors. J Hepatol. 1994;21:227–234
- In: Greene FL, Page DL, Fleming ID, et al. editor. Liver including intrahepatic bile ducts. In: American Joint Committee on Cancer Staging Manual. 6th ed.. New York: Springer; 2002;p. 131–144
- Serum concentrations of human hepatocyte growth factor is a useful indicator for predicting the occurrence of hepatocellular carcinomas in C-viral chronic liver diseases. Cancer. 2002;95:824–834
- . Gene expressions of c-met and hepatocyte growth factor in chronic liver disease and hepatocellular carcinoma. J Hepatol. 1996;24:286–292
- Expression of hepatocyte growth factor activator and hepatocyte growth factor activator inhibitor type 1 in human hepatocellular carcinoma. Biochem Biophys Res Commun. 2001;289:205–211
- Trans-resveratrol, a grapevine-derived polyphenol, blocks hepatocyte growth factor-induced invasion of hepatocellular carcinoma cells. Int J Oncol. 2001;19:83–88
- Inhibition of angiogenesis and HGF-cMET-elicited malignant processes in human hepatocellular carcinoma cells using adenoviral vector-mediated NK4 gene therapy. Cancer Gene Ther. 2005;12:954–962
PII: S0748-7983(06)00492-6
doi: 10.1016/j.ejso.2006.12.007
© 2006 Elsevier Ltd. All rights reserved.
« Previous
Next »
European Journal of Surgical Oncology
Volume 34, Issue 3
, Pages 333-338
, March 2008
